GPR183: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
 
(One intermediate revision by the same user not shown)
Line 23: Line 23:
[[Category:Immunology]]
[[Category:Immunology]]
{{medicine-stub}}
{{medicine-stub}}
{{No image}}
__NOINDEX__

Latest revision as of 13:14, 17 March 2025

GPR183 (G Protein-Coupled Receptor 183), also known as EBI2 (Epstein-Barr Virus Induced Gene 2), is a protein that in humans is encoded by the GPR183 gene. It is a member of the G protein-coupled receptor family and plays a crucial role in the immune system.

Function[edit]

GPR183 is a G protein-coupled receptor that is involved in the regulation of B cell function. It is expressed in various tissues with high levels in lymphoid tissues such as spleen, lymph node, and peripheral blood leukocytes. The receptor is activated by a lipid molecule called 7α,25-dihydroxycholesterol (7α,25-OHC) which is synthesized in response to inflammatory signals. This activation leads to the migration of B cells and other immune cells to the inflamed tissues.

Clinical Significance[edit]

Alterations in the GPR183 gene have been associated with various diseases. Overexpression of GPR183 has been observed in Hodgkin's lymphoma and diffuse large B cell lymphoma, suggesting a potential role in the pathogenesis of these diseases. In addition, GPR183 has been implicated in autoimmune diseases such as multiple sclerosis and systemic lupus erythematosus.

Research[edit]

Research is ongoing to understand the precise role of GPR183 in the immune system and its potential as a therapeutic target. Studies have shown that blocking the activity of GPR183 can reduce the severity of autoimmune diseases in animal models, suggesting a potential therapeutic strategy for these conditions.

See Also[edit]

References[edit]

<references />

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!